Targeted therapy of lung cancer

Targeted therapy of lung cancer refers to using agents specifically designed to selectively target molecular pathways responsible for, or that substantially drive, the malignant phenotype of lung cancer cells, and as a consequence of this (relative) selectivity, cause fewer toxic effects on normal cells. Most previous chemotherapy drugs for cancer were (relatively) nonselective in their activity.

This neuron ends here.